483 related articles for article (PubMed ID: 33656711)
1. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
Mezoh G; Crowther NJ
Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
4. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
[TBL] [Abstract][Full Text] [Related]
5. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
6. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Verdecchia P; Cavallini C; Spanevello A; Angeli F
Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.
Zhang J; Tecson KM; McCullough PA
Rev Cardiovasc Med; 2020 Sep; 21(3):315-319. PubMed ID: 33070537
[TBL] [Abstract][Full Text] [Related]
8. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
9. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
10. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
11. COVID-19: Catastrophic Cause of Acute Lung Injury.
Cai A; McClafferty B; Benson J; Ramgobin D; Kalayanamitra R; Shahid Z; Groff A; Aggarwal CS; Patel R; Polimera H; Vunnam R; Golamari R; Sahu N; Bhatt D; Jain R
S D Med; 2020 Jun; 73(6):252-260. PubMed ID: 32580257
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
Maruhashi T; Higashi Y
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
[TBL] [Abstract][Full Text] [Related]
14. The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19.
Six I; Guillaume N; Jacob V; Mentaverri R; Kamel S; Boullier A; Slama M
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682871
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
16. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
Front Immunol; 2020; 11():1714. PubMed ID: 32793244
[TBL] [Abstract][Full Text] [Related]
17. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
Seeherman S; Suzuki YJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
[TBL] [Abstract][Full Text] [Related]
18. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.
Maiuolo J; Mollace R; Gliozzi M; Musolino V; Carresi C; Paone S; Scicchitano M; Macrì R; Nucera S; Bosco F; Scarano F; Zito MC; Ruga S; Tavernese A; Mollace V
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291346
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
20. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
McGowan EM; Haddadi N; Nassif NT; Lin Y
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
